Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker

Overview of attention for article published in Glycoconjugate Journal, July 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 8,363 followers.

RT @SweetPaperBot: Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker #Glycotime #Glycoconj…

RT @SweetPaperBot: Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker #Glycotime #Glycoconj…

RT @SweetPaperBot: Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker #Glycotime #Glycoconj…

Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker #Glycotime #Glycoconjugate https://t.co/DL8vs7bdAq

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.